CAPECITABINE is a chemotherapy drug. It slows the growth of cancer cells. This medicine is used to treat breast cancer, and also colon or rectal cancer. Monotherapy (Metastatic Colorectal Cancer, Adjuvant Colorectal Cancer, Metastatic Breast Cancer) The recommended dose of XELODA is 1250 mg/m 2 administered orally twice daily (morning and evening; equivalent to 2500 mg/m 2 total daily dose) for 2 weeks followed by a 1-week rest period given as 3-week cycles (see Table 1). Chemocare.com está diseñado para proporcionar la información más reciente acerca de la quimioterapia para los pacientes y sus familias, cuidadores y amigos. Xeloda (Capecitabine) chemotherapy side effects, how it's given, how it works, precautions and self care tips for treatment of multiple cancers WARNING. XELODA-WARFARIN INTERACTION. XELODA Warfarin Interaction: Patients receiving concomitant capecitabine and oral coumarin-derivative anticoagulant therapy should have their anticoagulant response (INR or prothrombin time) monitored frequently in order to adjust the anticoagulant dose accordingly. Capecitabine (Xeloda®) is a chemotherapy drug. It is used to treat many types of cancer including breast, colon, rectal, stomach, oesophageal and pancreatic cancers. While chemotherapy and radiation have long been considered the gold standard for treating cancer, it’s not because they have been proven to cure cancer. A drug called Xeloda can extend the lives of some women whose breast cancer is not wiped out by standard treatment, a new clinical trial finds. Xeloda is the brand name of the medicine capecitabine, which is used alone or with other drugs to treat certain breast, colon, rectal, and stomach cancers. Capecitabine, sold under the brand name Xeloda among others, is a chemotherapy medication used to treat breast cancer, gastric cancer and colorectal cancer. For breast cancer it is often used together with docetaxel. It is taken by mouth.